Academe Learn
CBME Curriculum Preview

Page 20 of 20

IM3.1-22 | Pneumonia — PBL Case

CLINICAL SETTING

Dr Ramesh is the registrar on evening duty in the general medicine ward of a tertiary teaching hospital in Chennai. He is supervising Ananya, a final-year MBBS student who is completing her Internal Medicine clinical posting. A 58-year-old male farmer, Murugan, is brought in by his son at 8 PM. Murugan has been unwell for four days with high fever, productive cough, and right-sided chest pain that worsens with breathing. His son says: 'He was fine last week, then suddenly started shivering and his temperature went to 40 degrees. He has been coughing up something dark yellow-brownish, and he says it hurts to breathe deeply. He tried some paracetamol tablets but the fever keeps coming back.' Murugan has no prior history of hospitalisation, no known diabetes or hypertension, and takes no regular medications. He drinks country liquor socially, approximately 2-3 times a week. He is a non-smoker. He has not travelled recently. Ananya opens her clinical notebook and begins the history.

Trigger 1: The History and Examination — Clues in the Detail

Ananya completes a structured history. Key findings: fever for 4 days (maximum 40.1°C), cough productive of brownish-yellow sputum (no frank blood), right-sided pleuritic chest pain, one episode of rigors on day 1, and mild confusion since this morning (his son reports he 'doesn't seem to know what day it is'). There is no headache, neck stiffness, rash, or diarrhoea. He reports no sick contacts or recent air-conditioning exposure. He notices he has sores on his lower lip (herpes labialis). On examination: temperature 39.4°C, pulse 108/min, BP 104/68 mmHg, RR 28/min, SpO2 86% on room air. He is drowsy but rousable, oriented to name only. Chest examination: trachea central; right mid-zone — stony dullness on percussion, increased vocal resonance, bronchial breath sounds, and a pleural rub. Left lung clear. No lymphadenopathy. No pedal oedema. Dr Ramesh asks Ananya: 'Before we order anything, tell me your clinical assessment — what is happening, how severe is it, and what is your working diagnosis?'

DISCUSSION POINTS

  • What specific history features allow you to classify this as community-acquired pneumonia (CAP) rather than HAP, VAP, or aspiration pneumonia? Apply the definition precisely.
  • Calculate CURB-65 for Murugan using the clinical data provided. Score each criterion separately with the actual value. What site-of-care does the score recommend?
  • The right mid-zone shows stony dullness + increased vocal resonance + bronchial breath sounds + pleural rub. Explain the mechanism underlying each of these signs and what they collectively indicate.
Click to reveal Trigger 2: Investigations — Results Begin to Arrive (discuss previous trigger first!)

Trigger 2: Investigations — Results Begin to Arrive

Dr Ramesh orders urgent investigations. Results return over the next 90 minutes. CBC: Hb 13.2 g/dL, WBC 19,400/mm3 (neutrophils 88%, no toxic granulation noted), platelets 189,000/mm3. Urea 9.1 mmol/L, creatinine 1.3 mg/dL, sodium 136 mEq/L, potassium 4.0 mEq/L. CXR (PA view): right lower and mid-zone homogeneous opacification with blunting of the right costophrenic angle; small right pleural effusion; no air bronchograms visible; left lung clear. ABG on room air: pH 7.34, PaO2 54 mmHg, PaCO2 33 mmHg, HCO3 18 mEq/L. Sputum Gram stain: numerous Gram-positive diplococci; >25 PMNs per low-power field; fewer than 10 squamous epithelial cells per field. Blood cultures x2 drawn before antibiotics. Ananya looks at the results and says: 'The sputum looks straightforward — but what do we do about that pleural effusion?' Dr Ramesh replies: 'Good question. We need to decide whether it needs to be tapped tonight, and if so, what we are looking for.' The registrar also reminds Ananya: 'We have not started antibiotics yet. Before we prescribe, what do we know and what do we need to decide?'

DISCUSSION POINTS

  • Interpret the ABG step by step: classify the acid-base disorder, determine if it is acute or chronic, and state what this result implies about the patient's respiratory reserve and immediate oxygen management.
  • The sputum Gram stain shows Gram-positive diplococci in a good-quality specimen. What is the likely organism? What does this finding allow us to infer about empirical antibiotic selection, even before culture results?
  • Should the pleural effusion be tapped tonight? What clinical and radiological features would make thoracentesis urgent, and what pleural fluid parameters would distinguish a simple parapneumonic effusion from an empyema requiring drainage?
Click to reveal Trigger 3: Management Decisions — Prescribing and Monitoring (discuss previous trigger first!)

Trigger 3: Management Decisions — Prescribing and Monitoring

The team decides to tap the effusion. Thoracentesis yields 120 mL of turbid straw-coloured fluid. Pleural fluid results: pH 7.18, glucose 2.0 mmol/L, protein 46 g/L (serum protein 68 g/L), LDH 420 U/L (serum LDH 195 U/L), Gram stain: no organisms seen. Dr Ramesh starts empirical antibiotics. Supplemental oxygen is given via a non-rebreather mask. By 2 AM, Murugan's SpO2 is 94%. Over the next 48 hours, however, he continues to have fever spikes to 38.5°C despite antibiotics. The blood culture from admission returns positive: Streptococcus pneumoniae, sensitive to penicillin (MIC 0.12 mcg/mL), sensitive to amoxicillin, resistant to erythromycin. The pleural fluid culture comes back: no growth. Chest X-ray at 48 hours shows the effusion is unchanged. Ananya asks: 'If the blood culture shows the correct organism and he is on the right antibiotic, why is he still febrile?'

DISCUSSION POINTS

  • Classify the pleural effusion using Light's criteria — show the calculations. Does this require drainage? What specific criterion is decisive?
  • The blood culture confirms penicillin-sensitive Streptococcus pneumoniae. Is IV ceftriaxone the correct antibiotic for bacteraemic pneumococcal pneumonia? What is the pharmacological rationale for beta-lactam efficacy against this organism?
  • The effusion is unchanged at 48 hours and the patient is still febrile despite correct antibiotics. What are the possible explanations? What investigation and management change would you make at this point?
Click to reveal Trigger 4: Communication, Counselling, and Discharge Planning (discuss previous trigger first!)

Trigger 4: Communication, Counselling, and Discharge Planning

By day 5, Murugan meets clinical stability criteria: afebrile for 36 hours, RR 18/min, SpO2 96% on room air, tolerating oral diet, oriented and alert. The effusion has reduced on repeat CXR. The team plans oral antibiotics and discharge in 24 hours. Murugan's son asks the ward team: 'My father has never been this ill. Can this happen again? He is also worried because someone told him he might need an injection every year — is that true? And should he get the COVID booster too?' Ananya is asked to explain the diagnosis, discharge instructions, and vaccination plan to Murugan and his son in their preferred language (Tamil), using simple terms. Dr Ramesh observes and debriefs Ananya afterwards: 'Good — but you missed one important counselling point about his alcohol use and aspiration risk. What would you add?'

DISCUSSION POINTS

  • Murugan is ready for IV-to-oral switch. State the clinical stability criteria that must be met before switching. Which oral antibiotic would you prescribe, at what dose and for how long, given the culture result (penicillin-sensitive S. pneumoniae, macrolide-resistant)?
  • Counsel Murugan on pneumococcal and influenza vaccination: which vaccines, when to give them, and whether they need annual repetition. Apply current Indian/international guidelines.
  • Dr Ramesh identified a missed counselling point about alcohol and aspiration risk. What is the specific aspiration risk associated with alcohol use, and how would you counsel Murugan in culturally appropriate terms?

Group Task Assignments

  • Construct a complete management protocol for a patient with CURB-65 3 CAP and a parapneumonic effusion: include the antibiotic regimen (drug, dose, route, duration), oxygen strategy, pleural effusion decision algorithm (tap/drain criteria), IV-to-oral switch criteria, and 48-72 hour review checklist.
  • Compare CAP, HAP, and aspiration pneumonia on four dimensions: acquisition setting and definition, most likely pathogens (list 3 per syndrome), first-line empirical antibiotic regimen (drug, dose, route), and one key management difference from CAP. Present as a structured comparison table.
  • Murugan's son asks: 'Is my father's pneumonia contagious — should we isolate him at home?' Debate the isolation and barrier nursing requirements for: (a) bacterial CAP with confirmed S. pneumoniae, (b) pulmonary tuberculosis (AFB smear 2+), (c) influenza pneumonia. For each, state the transmission route, required precautions, and duration.
  • Prepare a patient-appropriate discharge leaflet in plain English (which could then be translated to Tamil) for Murugan: covering the diagnosis in lay terms, what to expect during recovery, medication instructions, red-flag symptoms requiring return to hospital, and vaccination recommendations.

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [IM3.1] What are the defining criteria that distinguish community-acquired pneumonia (CAP) from hospital-acquired pneumonia (HAP) and aspiration pneumonia — and why does the classification matter for management?
  2. [IM3.2] What is the microbiology of CAP in India — which organisms are typical vs atypical, and how does alcoholism or immune suppression change the expected pathogen spectrum?
  3. [IM3.3] What is the natural history of untreated pneumococcal pneumonia — what complications can develop (parapneumonic effusion, empyema, lung abscess, septicaemia) and what are the pathological stages of lobar consolidation?
  4. [IM3.9] How do you interpret an ABG step by step — and what does acute respiratory acidosis in a patient with CAP indicate about their immediate management?
  5. [IM3.11] How do you classify a pleural effusion using Light's criteria, and which pleural fluid parameters (pH, glucose, LDH, Gram stain, culture) determine whether drainage is required?
  6. [IM3.15] What is the evidence-based empirical antibiotic regimen for CAP stratified by CURB-65 severity — and what is the pharmacological rationale for each choice?
  7. [IM3.17] What are the CURB-65 criteria and how does the score determine the site-of-care decision — outpatient, ward admission, or ICU — for patients with CAP?
  8. [IM3.19] What are the oxygen targets and escalation thresholds in pneumonia — when do you use high-flow oxygen, non-invasive ventilation, or intubation?